Results obtained from a cross-sectional study in African American adults at risk of cardiovascular disease showed that TMAO induces hyperlipidemia through proprotein convertase subtilisin/kexin type 9 (PCSK9) and this pathway is mediated by IL-8 [93]. This evidence concerns the gene PCSK9 and hyperlipidemia.